
Redalpine
Zurich-based venture capital firm; ~€1.5bn AUM; early-stage tech across Europe and Israel.
Last refreshed: 7 June 2026 · Appears in 1 active topic
What does Redalpine's deep-tech focus say about European early-stage appetite in 2026?
Timeline for Redalpine
Apoha bets £26.7m on lab data
UK Startups and Innovation9fin crosses unicorn threshold at $170m
UK Startups and InnovationWho is Redalpine and what do they invest in?
What is Redalpine's involvement in the Apoha round?
How is Redalpine different from other European VCs?
Background
Redalpine is a Zurich-based venture capital firm founded in 2007 that manages approximately €1.5bn across multiple funds, investing primarily in early-stage technology companies across Europe and Israel. The firm focuses on seed to Series B rounds in fintech, enterprise software, health technology, and deep technology, with a portfolio that spans Taxfix, Aeye, Testbirds, 9fin, and a range of B2B software businesses. It operates from offices in Zurich and Berlin.
Redalpine's investment approach is characterised by a willingness to back technical founders at early stages and follow through to later rounds, maintaining portfolio positions across multiple fund vintages. The firm has a particular record in B2B software with network-effect moats, illustrated by its long-running position in 9fin from early stage through to the $170m Series c unicorn round in March 2026. Its geographic spread across both Switzerland and Germany, and a stated commitment to European and Israeli ecosystems, distinguishes it from London-centric growth funds.
Switzerland's institutional capital base has historically been under-represented in venture relative to its economic weight, but firms like Redalpine have built genuine pan-European track records. At €1.5bn AUM, Redalpine sits at the larger end of European early-stage managers, giving it the capacity to write meaningful cheques at both seed and Series A stages and to participate in later rounds alongside growth equity specialists.
On this beat, Redalpine's most recent move is co-investing in Apoha's £26.7m ($36m) round in June 2026. Apoha, a London-based deep-tech company, is building an empirical molecular-behaviour data layer for physical-world AI, assembling laboratory data that cannot be synthesised from internet text. The round was led by Singular, with Seedcamp and Draper Associates also following, alongside an Innovate UK grant. Redalpine's participation signals its appetite for deep-tech infrastructure plays that sit below the application layer.
Redalpine also participated in 9fin's $170m Series c unicorn round in March 2026, continuing the backing it established at an earlier stage in the debt-data platform's development. The two UK investments in 2026 together cover very different sectors (credit-market data and molecular deep tech) and reflect the breadth of Redalpine's European mandate rather than a UK-specific thesis.